Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | ADORA2B | P29275 | 6/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SCD | O00767 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bisdisulizole SCHEMBL7706777 | 1.00 | HDAC6 (0.49) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| SCHEMBL18159480 | 0.93 | SCD (0.47) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| SCHEMBL7190581 | 0.93 | HDAC6 (0.59) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| SCHEMBL25769743 | 0.92 | HDAC6 (0.43) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| SCHEMBL15436778 | 0.91 | HDAC6 (0.51) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| SCHEMBL15436708 | 0.90 | HDAC6 (0.67) | HDAC6CYP2C19SCDCYP2D6CYP3A4 | |
| SCHEMBL6566428 | 0.83 | HDAC6 (0.41) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| SCHEMBL10608670 | 0.78 | HDAC6 (0.33) | HDAC6ALDH1A1HSD17B10CYP2C19CYP2C9 | |
| SCHEMBL12866609 | 0.78 | HDAC6 (0.55) | HDAC6ADORA2BADORA2AKDM4EALDH1A1 | |
| Bisdisulizole SCHEMBL29507102 | 0.76 | HDAC6 (0.52) | HDAC6ADORA2BKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4201411-A1 | NOVEL USE OF VITAMIN B12 | DSM IP Assets B.V. (NL) | 2023-06-28 | — | — | EP | disclosed |
| EP-4201410-A1 | NOVEL USE OF VITAMIN B12 | DSM IP Assets B.V. (NL) | 2023-06-28 | — | — | EP | disclosed |
| CN-106132386-B | Topical compositions | 帝斯曼知识产权资产管理有限公司 | 2020-06-02 | — | — | CN | disclosed |
| EP-3125856-B1 | TOPICAL COMPOSITIONS | DSM IP ASSETS BV (NL) | 2019-07-03 | — | — | EP | disclosed |
| EP-3019142-B1 | UV SCREENING COMPOSITION COMPRISING A UV FILTER, AN ORGANOPOLYSILOXANE FUNCTIONALIZED WITH A UV ABSORBER AND POROUS SILICA AND / OR POLYMETHYLMETHACRYLATE PARTICLES | DSM IP ASSETS BV (NL) | 2017-10-04 | — | — | EP | disclosed |
| US-20170087069-A1 | TOPICAL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2017-03-30 | — | — | US | disclosed |
| EP-3125856-A1 | TOPICAL COMPOSITIONS | DSM IP Assets B.V. (NL) | 2017-02-08 | — | — | EP | disclosed |
| US-20160303020-A1 | SUNSCREEN COMPOSITION | JOHNSON & JOHNSON CONSUMER INC. | 2016-10-20 | — | — | US | disclosed |
| US-20160143831-A1 | UV SCREENING COMPOSITION COMPRISING A UV FILTER, AN ORGANOPOLYSILOXANE FUNCTIONALIZED WITH A UV ABSORBER AND POROUS SILICA AND/OR POLYMETHYLMETHACRYLATE PARTICLES | DSM IP ASSETS B.V. (NL) | 2016-05-26 | — | — | US | disclosed |
| EP-3019142-A1 | UV SCREENING COMPOSITION COMPRISING A UV FILTER, AN ORGANOPOLYSILOXANE FUNCTIONALIZED WITH A UV ABSORBER AND POROUS SILICA AND/OR POLYMETHYLMETHACRYLATE PARTICLES | DSM IP Assets B.V. (NL) | 2016-05-18 | — | — | EP | disclosed |
| WO-2015150169-A1 | TOPICAL COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2015-10-08 | — | — | WO | disclosed |
| WO-2015003987-A1 | UV SCREENING COMPOSITION COMPRISING A UV FILTER, AN ORGANOPOLYSILOXANE FUNCTIONALIZED WITH A UV ABSORBER AND POROUS SILICA AND/OR POLYMETHYLMETHACRYLATE PARTICLES | DSM IP ASSETS B.V. (NL) | 2015-01-15 | — | — | WO | disclosed |
| WO-2008055983-A1 | COMPOSITION COMPRISING A SULFONATED ACTIVE SUBSTANCE AND CATIONIC COMPOUND | BASF SE (DE) | 2008-05-15 | — | — | WO | disclosed |
| US-6368578-B1 | MIXTURE | BEIERSDORF AG (DE) | 2002-04-09 | — | — | US | disclosed |
| US-6355230-B2 | FOR ULTRAVIOLET-A RADIATION PROTECTION; SOLUBILITY | BEIERSDORF AG (DE) | 2002-03-12 | — | — | US | disclosed |
| US-20010026790-A1 | Cosmetic and dermatological light protection formulations wirh a content of benzotriazole derivatives and alkyl naphthalates | BEIERSDORF AG (DE) | 2001-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160143831-A1 | UV SCREENING COMPOSITION COMPRISING A UV FILTER, AN ORGANOPOLYSILOXANE FUNCTIONALIZED WITH A UV ABSORBER AND POROUS SILICA AND/OR POLYMETHYLMETHACRYLATE PARTICLES | RAD50, SERPINB10, XRCC5 | HDAC6 696/4885ADORA2B 2247/4885ADORA2A 3357/4885 |
| US-20160303020-A1 | SUNSCREEN COMPOSITION | ERCC5, ERCC1, ERCC4 | HDAC6 416/4885ADORA2B 4043/4885ADORA2A 3642/4885 |
| US-20010026790-A1 | Cosmetic and dermatological light protection formulations wirh a content of benzotriazole derivatives and alkyl naphthalates | WHR1, WIZ, LBR | HDAC6 1445/4885ADORA2B 1167/4885ADORA2A 809/4885 |
| US-20170087069-A1 | TOPICAL COMPOSITIONS | DSG1, RAD50, PLIN5 | HDAC6 2431/4885ADORA2B 3720/4885ADORA2A 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.